Chimeric antigen receptor T-cells might unmask transdifferentiated histiocytic sarcoma during diffuse large B-cell lymphoma treatment

Click to increase image sizeClick to decrease image size

Acknowledgements

C.G., B.S., M.H., and L.Z. each participated in the care of the patient. C.G. drafted the manuscript. All authors reviewed, revised, and approved the final manuscript for submission. The authors thank G.H. for his thoughtful editing of the manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.